Navigation Links
OrthoAccel Technologies, Inc. Announces Definitive Distribution Agreements in Two Key Markets
Date:8/24/2010

HOUSTON, Aug. 24 /PRNewswire/ -- OrthoAccel Technologies, Inc. announced this week that it has finalized distribution agreements with two key partners:  AB Orthodontics Pty Ltd in Melbourne, Australia, and Inno Dental and Medical Corporation (Inno DMC), based in Seoul, South Korea.  

(Logo:  http://photos.prnewswire.com/prnh/20091029/DA01250LOGO)

(Logo:  http://www.newscom.com/cgi-bin/prnh/20091029/DA01250LOGO)

The AcceleDent System is currently being sold to select orthodontic specialists in the United Kingdom, where it was introduced last year through a limited release market program.  The lightweight device, used to speed up the rate of orthodontic treatment, is intended for 20 minutes of daily use.  Patients simply bite down on the Mouthpiece to hold it in place, which allows freedom of the hands to engage in other routine, daily activities during the treatment session.  Patients have reported using the device while engaged in a variety of activities, including homework, watching television and commuting to work.  The Company has reported plans for a general market release in the United Kingdom in September, at the British Orthodontic Conference in Brighton.

Mike Kaufman, VP of Marketing and Business Development for OrthoAccel commented, "Australia and South Korea are key international markets for us and allow us to develop product awareness and success stories in advance of a future release in other international markets and the United States."

This definitive distribution agreement between OrthoAccel and AB Orthodontics formalizes the intent to partner together that was reported by the two companies in May.  " The AcceleDent device has received much positive interest from the Australian orthodontic community including academics and researchers. Some orthodontists have reported excellent initial results, especially in cases where tooth movement has been very slow or virtually unachievable," stated Andrew Binns, Managing Director.  On October 18-22 AB Orthodontics is preparing to host AcceleDent seminars in Sydney, Melbourne and Brisbane with Dr. Asif Chatoo as the keynote speaker.  Dr Chatoo, who practices at the Lingual Orthodontic Clinic, was among the first users of the AcceleDent System in the United Kingdom.

The agreement with Inno DMC marks OrthoAccel's first movement into the Asia Pacific region.  Mr. Sung-ku Hong, CEO of Inno DMC, commented, "AcceleDent is an exciting and new innovative technology with the potential to offer significant time savings to the patient and practice efficiencies to the orthodontist."  Mike Kaufman added, "OrthoAccel first had the opportunity to meet with Mr. Hong during the 2010 AAO meeting and we immediately appreciated the depth and experience of Inno DMC and how their relationships with the orthodontic community would benefit our efforts in South Korea."  Although commercial sales are not anticipated until next year because regulatory details must be finalized, efforts to begin increasing awareness and educating dental professionals will begin immediately.  

OrthoAccel is anticipating the conclusion of another US clinical trial at the UT Health Science Center in San Antonio with a target completion date later in 2010.

About OrthoAccel Technologies, Inc.

Based in Houston, Texas, OrthoAccel Technologies, Inc. is a privately owned medical device company currently engaged in the development, manufacturing, and marketing of products to enhance dental care and orthodontic treatment.  

About the AcceleDent System

AcceleDent represents the first clinical approach to safely accelerate orthodontic tooth movement via modulating biology.  The device has been studied clinically and applies gentle pulsing forces in combination with standard orthodontics to move teeth faster through accelerated bone remodeling.  Importantly, the device works complementary with all existing orthodontic technologies.  AcceleDent is neither FDA cleared nor FDA approved; it is currently investigational only in the United States.  More information can be found at www.acceledent.com or requested via info@orthoaccel.com


'/>"/>
SOURCE OrthoAccel Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. OrthoAccel Technologies, Inc. and AB Orthodontics Announce Partnership and Australian Product Introduction
2. New Report - Telemedicine Market in Brazil, Russia, India, China (BRIC) - Advanced Technologies, Global Forecast by MarketsandMarkets
3. Palatin Technologies, Inc. Announces Positive Safety Results in Subcutaneous Bremelanotide Trial in Men
4. Wound Management Technologies, Inc. Expands Distribution Channel into Five Central American Countries
5. Palatin Technologies, Inc. Receives $2.5 Million from AstraZeneca
6. Patient Safety Technologies, Inc., Contracts to Implement the Safety-Sponge(TM) System at The Mount Sinai Hospital in New York
7. Palatin Technologies, Inc. To Raise $2.6 Million Dollars in Registered Direct Offering
8. Palatin Technologies, Inc. Announces Dosing of Subcutaneous Bremelanotide Trial in Men
9. Wound Management Technologies, Inc. Engages Miller Tabak, A National Investment Banking Firm Specializing in the Healthcare Market Space
10. Wound Management Technologies, Inc. Targets Multi-Billion Dollar Biomaterials Market; Releases Update on Resorbable Orthopedics
11. AVAX Technologies, Inc. Closes Bridge Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2017)...   CerSci Therapeutics , a non-opioid drug development ... has received notice from the National Institute on Drug ... that it has been awarded a Direct-to-Phase II Small ... 2017 with an additional $1,000,000 to follow in 2018. ... of their lead non-opioid drug candidate CT-044 to the ...
(Date:7/31/2017)... , July 31, 2017 7D Surgical, developer of ... has purchased the 7D Surgical System to support its strategic ... Washington D.C. and Virginia.  7D Surgical has entered ... many of the premier medical facilities within those markets. ... ...
(Date:7/27/2017)... 27, 2017  Zimmer Biomet Holdings, Inc. (NYSE and ... June 30, 2017.  The Company reported second quarter net ... the prior year period, and an increase of 2.1% ... points of contribution from the LDR Holding Corporation acquisition, ... quarter of 2016, or 0.3% on a constant currency ...
Breaking Medicine Technology:
(Date:8/22/2017)... ... ... “Glimpses Of Light”: is a unique and thought inspiring guide toward self-discovery ... published author, J.M. Shepherd, a writer, teacher, traveler, and metaphysician, the author has spent ... shares, “Love is one of the least understood and yet most sought-after pleasures known ...
(Date:8/21/2017)... ... August 22, 2017 , ... PracticeMatch, a company that ... healthcare employers connect with physicians and advanced practitioners like nurse practitioners and ... in August through November of this year. The online career fairs will allow ...
(Date:8/21/2017)... (PRWEB) , ... August 21, 2017 , ... ... today announced that it has become the Official Technology Partner of North Country ... AES (Advanced Event Systems) volleyball software, along with providing sport management software ...
(Date:8/21/2017)... ... ... PIXACORE , an independent full-service agency with a decade of experience ... year by MM&M. , This is the first time PIXACORE has made the Top ... PIXACORE’s newfound recognition reflects its steady trajectory of growth and recent strategic transformation. ...
(Date:8/20/2017)... ... August 20, 2017 , ... A total solar eclipse will occur across the ... as the moon moves between the sun and Earth. This rare event will be magnificent ... can help keep you safe on the road during the total eclipse of the sun. ...
Breaking Medicine News(10 mins):